Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance and develop healthcare and life science businesses that deliver or seek to deliver innovative therapies to patients. Its segment includes sourcing, financing and developing healthcare and life science businesses globally. The company's revenue is derived from the United Kingdom.
London, W1K 6JL, United Kingdom